FREE Case Evaluation: 1-888-887-3117
Roundup litigation updates reveal a massive legal battle is still unfolding. Despite Bayer settling nearly 100,000 claims for $11 billion, over 67,000 cases remain pending. Here's the current status:
Current Status (2025):
Key Recent Developments:
The litigation shows no signs of slowing. Combined jury awards in 2023-2024 exceeded $3 billion, and individual settlements range from $5,000 to over $2 million. People who used Roundup regularly and developed non-Hodgkin's lymphoma or other linked cancers may still qualify to file a claim, but it's crucial to act before the statute of limitations expires.
I'm Tim Burd, founder of Justice Hero. My team has connected over 50,000 plaintiffs with experienced attorneys in various product liability cases, and we're here to help you steer the complexities of mass tort litigation like the Roundup lawsuits.
The Roundup litigation is one of the largest mass torts in U.S. history, involving tens of thousands of cases and billions in settlements. The fight shows no signs of slowing down.
Much of the federal litigation is consolidated in Multidistrict Litigation (MDL) 2741 in the Northern District of California, overseen by Judge Vince Chhabria. This MDL streamlines pretrial proceedings for thousands of cases. Simultaneously, state courts are handling their own dockets, with New Jersey recently granting Multicounty Litigation (MCL) status for Roundup lawsuits, increasing pressure on Bayer. At Justice Hero, we provide clear, up-to-date information through our Roundup Class Action Lawsuit Update resource.
Since acquiring Monsanto in 2018, Bayer's primary strategy has been financial settlement. As of 2025, Bayer has paid approximately $11 billion to resolve nearly 100,000 Roundup lawsuits. This is part of a $16 billion total fund allocated for current and future claims. These complex settlements aim to compensate victims while providing Bayer with some financial certainty. For details on how these settlements work, see our guide on Roundup Settlement Payments.
Despite the massive payouts, the litigation is far from over. Roughly 67,000 active Roundup lawsuits are still pending as of 2025. Over 4,000 of these cases are in the federal MDL 2741. State courts are also active, with New Jersey's new MCL status streamlining 36 cases across eight counties.
The caseload continues to grow, with more than 4,000 new cases added to the federal MDL in August 2024 alone. This influx of new plaintiffs highlights the "long tail" of toxic tort liability, where injuries like cancer manifest years after exposure. Judge Chhabria continues to manage the federal cases, while state court actions add pressure on Bayer to consider broader settlement strategies. For a history of these lawsuits, explore our guide: Monsanto Vs. The Public: A Guide To All Lawsuits Filed Against Monsanto.
Recent roundup litigation updates show that lawsuits remain viable in 2025, with major verdicts and key legal decisions shaping the future of this battle. Despite Bayer's settlement efforts, juries continue to side with plaintiffs in bellwether trials, which serve as powerful indicators for how thousands of other cases might resolve.
These verdicts and appeals directly impact settlement values and the viability of new cases. For the most current information, check our Latest Roundup Lawsuit Update.
Combined jury awards in 2023-2024 exceeded $3 billion, showing that juries are not persuaded by Bayer's defense arguments. Key recent verdicts include awards of $2.25 billion, $332 million, and $175 million. In June 2025, a Missouri court also upheld a $1.25 million verdict. This pattern of plaintiff victories has impacted Bayer's financial standing, contributing to a 4.5% stock drop in June 2025.
However, large awards can be reduced on appeal. For example, a California appellate court struck a $75 million punitive damages award in June 2025. This highlights the complex path from verdict to final payment, though the overall trend still favors plaintiffs, particularly in the St. Louis trials. For more on how verdicts influence case values, visit our Roundup Case Settlement page.
Bayer's primary legal strategy is based on "federal preemption"—the argument that federal law should override state-level failure-to-warn claims. Bayer contends that since the EPA approved Roundup's label without a cancer warning, states cannot require one. Plaintiffs counter this by citing the International Agency for Research on Cancer (IARC), which classified glyphosate as a "probable human carcinogen" in 2015.
In a critical development in June 2025, the U.S. Supreme Court asked the Department of Justice's opinion on Bayer's appeal. This request to the Solicitor General indicates the Court is seriously considering the case. A ruling for Bayer could end thousands of state lawsuits, while a ruling against them would significantly strengthen the plaintiffs' position. The case centers on the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), and the Court's decision will be a landmark event in this litigation.
The litigation remains highly active:
These events show that roundup litigation updates remain dynamic and favorable to plaintiffs. For the latest news, see our Roundup Weed Killer Lawsuit Update.
The scientific debate over whether Glyphosate, Roundup's active ingredient, causes cancer is the foundation of this litigation. This dispute fuels the ongoing legal battles discussed in roundup litigation updates.
The core conflict began in 2015 when the International Agency for Research on Cancer (IARC) classified glyphosate as a "probable human carcinogen." This contradicted the EPA's position that glyphosate is not likely to be carcinogenic. This disagreement provides legal ammunition for both sides: plaintiffs cite the IARC, while Bayer points to the EPA. However, juries have consistently found that Bayer failed to warn consumers of potential risks, regardless of the EPA's stance. For a deeper dive, see our guide: Can Roundup Cause Cancer?
The science is not static. In June 2025, a major new study from the Ramazzini Institute published in Environmental Health found that glyphosate caused multiple cancers, including leukemia, in rats at doses previously considered "safe" by regulators. This research is significant because it suggests that even low-level exposure—common for homeowners and agricultural workers—can be dangerous. This type of independent evidence strengthens plaintiffs' claims that Roundup poses a significant health risk. To understand risk levels, see How Much Exposure To Roundup Is Dangerous?.
While Non-Hodgkin's Lymphoma is the most common cancer in these lawsuits, several others are also linked to glyphosate exposure. These include:
These cancers often have a latency period of 5 to 15 years, meaning a diagnosis today could be linked to Roundup use from years ago. If you have been diagnosed with one of these cancers and have a history of Roundup use, you may be eligible to file a claim. For more details on qualifying cancers, read our guide: What Cancers Are Included In The Roundup Lawsuit.
If you've been diagnosed with cancer after using Roundup, you may still have legal options. Roundup litigation updates confirm that new claims are being filed and compensated, despite Bayer's previous settlements. The company faces "long-tail liability" as new cases emerge years after exposure. Understanding your eligibility is the first step. Our guide on How To Join Roundup Lawsuit explains the process.
Eligibility hinges on proving a link between your cancer and significant Roundup use. Key factors include:
Eligibility criteria can change, so even if you were previously denied, it may be worth re-evaluating your case. For help, see our resource on the Best Lawyer For Roundup Lawsuit.
Settlements are calculated using a points system based on individual case factors:
Individual payouts have ranged from $5,000 to over $2 million, with most falling between $100,000 and $2 million. Ongoing plaintiff victories in court help keep settlement values strong. For more on payout ranges, visit What Is The Average Payout For Roundup Lawsuit?.
Bayer is using a multi-pronged strategy to limit future claims. This includes product changes, such as replacing glyphosate-based Roundup on retail shelves with new formulas, although professional versions still contain glyphosate.
Legally, their main effort is the Supreme Court appeal on federal preemption. A win could block future state-level claims. If they lose, they have a $4 billion fund for an administrative claims process to handle future cases. The company's stock performance reflects this pressure, and their overall strategy appears focused on managing costs rather than fighting every case, creating opportunities for plaintiffs. For updates on Bayer's strategy, see our Latest News On Roundup Settlement.
Here are answers to the most common questions we receive about the Roundup litigation.
Most Roundup cases take 18 to 36 months to resolve. The timeline is influenced by several factors, including the structured phases of the federal MDL, settlement negotiation timelines, individual case complexity, and court backlogs. Despite these factors, roundup litigation updates confirm that cases are actively moving forward, with regular settlements and verdicts.
A strong case requires evidence connecting your cancer diagnosis to Roundup exposure. Key evidence includes:
For more guidance, see our resource on What Proof Do You Need For Roundup Lawsuit?.
It is not necessarily too late, but you must act quickly. Your ability to file depends on your state's statute of limitations, which sets a strict deadline. This deadline typically starts from the date of your diagnosis or when you reasonably should have known your cancer was linked to Roundup (the "findy rule").
These deadlines are final, and strong cases have been dismissed for being filed too late. Given that courts are still accepting new cases and legal precedents are evolving, it is critical to get a professional evaluation of your situation immediately. Do not assume you are out of time. For help gathering evidence, visit our guide on How To Gather Evidence For Your Roundup Cancer Lawsuit.
The roundup litigation updates show a legal battle that is far from over. Despite $11 billion in settlements, approximately 67,000 lawsuits are still pending. This fight for justice is defined by several key trends:
For families affected by Roundup exposure, legal options remain available, but time is critical due to state statutes of limitations. Waiting too long can result in your case being dismissed.
At Justice Hero, we cut through the legal complexity to help you understand your rights. If you used Roundup and developed non-Hodgkin's lymphoma or a related cancer, it is vital to explore your options now. This fight is about holding corporations accountable. To learn more about your potential claim, visit our comprehensive resource: Learn more about the Roundup Lawsuit and your legal options. Our team can help connect you with experienced attorneys to fight for the justice you deserve.
